Efficacy of trovafloxacin (CP-99,219), a new fluoroquinolone, in an animal model of intraabdominal sepsis

被引：12

作者：

Onderdonk, AB

机构：

[1] BRIGHAM & WOMENS HOSP,DEPT MED,CHANNING LAB,BOSTON,MA 02115

[2] BRIGHAM & WOMENS HOSP,DEPT PATHOL,CHANNING LAB,BOSTON,MA 02115

[3] HARVARD UNIV,SCH MED,BOSTON,MA

来源：

关键词：

D O I：

10.1097/00019048-199606001-00007

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：S117 / S119

页数：3

共 12 条

[1]

CISNEROS RI, 1989, CURR THER RES CLIN E, V46, P5959

[2]

CISNEROS RL, 1986, CURR THER RES CLIN E, V39, P745

[3]

CISNEROS RL, 1990, CURR THER RES CLIN E, V48, P1021

[4]

CISNEROS RL, 1996, MICROECOLOGY THERAPY, V25, P368

[5]

CISNEROS RL, 1988, CURR THER RES CLIN E, V43, P16

[6]

CISNEROS RL, 1992, 4 EUR C 2 INT S ANA

[7]

GIRARD AE, 1993, 33 INT C ANT AG CHEM

[8]

GOOTZ TD, 1994, DIAGN MICR INFEC DIS, V19, P235

LOUIE, TJ ;

TALLY, FP ;

BARTLETT, JG ;

GORBACH, SL .

[10]

LOUIE TJ, 1977, J INFECT DIS, V135, P518